Adagene INC Schedule 13G passive stakes

WuXi PharmaTech Healthcare Fund I L.P. and WuXi AppTec Co., Ltd. have updated their Schedule 13G filing regarding their beneficial ownership of Adagene Inc. ordinary shares.

Janus Henderson Group plc has reported beneficial ownership of 10.1% of Adagene Inc.'s American Depository Receipts, holding 6,666,666 shares.

Jorey Chernett has reported a 5.1% beneficial ownership stake in Adagene Inc.'s ordinary shares, as detailed in a recent Schedule 13G filing.

Vincent C. Smith and affiliated entities have reported an aggregate beneficial ownership of 8.7% of Adagene Inc.'s Ordinary Shares.

WuXi PharmaTech Healthcare Fund I L.P. and WuXi AppTec Co., Ltd. have disclosed a 7.0% beneficial ownership stake in Adagene Inc. as of September 30, 2025.

Panacea Venture Healthcare Fund II and related entities have filed an Amendment No. 3 to their Schedule 13G, disclosing a 3.8% beneficial ownership in Adagene Inc. as of September 30, 2025.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a beneficial ownership of 0.9% of Adagene Inc.'s common stock as of June 30, 2025.

WuXi PharmaTech Healthcare Fund I L.P. and its indirect parent, WuXi AppTec Co., Ltd., have reported a shared beneficial ownership of 8.5% in Adagene Inc., totaling 4,978,628 ordinary shares as of March 31, 2025.

FIL Limited, along with Pandanus Partners, L.P. and Pandanus Associates, Inc., has filed an amended Schedule 13G disclosing a beneficial ownership of 1.8% of Adagene Inc.'s common stock as of March 31, 2025.

Panacea Venture Healthcare Fund II, L.P., along with its related entities and principal James Huang, has disclosed a 5.5% beneficial ownership stake in Adagene Inc.'s Ordinary Shares as of December 31, 2024.

FIL Limited, along with Pandanus Partners, L.P. and Pandanus Associates, Inc., has reported a continued beneficial ownership of 7.8% in ADAGENE INC's common stock as of December 31, 2024.

A Schedule 13G filing reveals that Vincent C. Smith, along with Red Beard Holdings, LLC and VCS Master Holdings GP, collectively hold a 6.9% passive beneficial ownership stake in Adagene Inc.'s Ordinary Shares.

OT Healthcare Fund I, along with its affiliates OT Management, LLC and Nichola Eliovits, has disclosed a beneficial ownership of 8.1% in Adagene Inc.'s ordinary shares.